{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:14:37Z","timestamp":1794575677053,"version":"4.9.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","funder":[{"DOI":"10.13039\/spabbkyhlkde","name":"President\u2019s Translational and Entrepreneurial Research Fund (PTEF) University of Texas Health Science Center at San Antonio, TX","doi-asserted-by":"publisher","id":[{"id":"10.13039\/spabbkyhlkde","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>The aim of this study was to evaluate whether an ultra-low dose of recombinant human bone morphogenetic protein-2 (rhBMP-2) delivered within a biomimetic hematoma (BH) scaffold could regenerate a large bone defect in goats more efficiently than a high dose of rhBMP-2 delivered on an absorbable collagen sponge (ACS). The BH is an autologous scaffold, created from whole blood and defined concentrations of coagulants, and is designed to closely mimic the structural and biological properties of a naturally healing fracture hematoma. It initiates the body's intrinsic healing cascade, thereby recapitulating the sequential phases of bone repair.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>A 2.5-cm defect was created in goat tibias and treated with either a BH scaffold containing ultra-low doses of rhBMP-2 (210 and 42 \u03bcg) or ACS with 2.1 mg of rhBMP-2. Empty defects and contralateral tibias served as controls. Bone regeneration was evaluated biweekly using radiographs and further assessed with micro-CT and histology at 8 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      A total of 12 specimens, three per group, were used for radiographic, micro-CT, and histological evaluations. By 8 weeks, radiographic scores showed complete regeneration in the BH+210 \u00b5g (5.0 \u00b1 0.0) and BH+42 \u00b5g (4.7 \u00b1 0.2) groups. The ACS+2.1 mg group scored 4.3 \u00b1 0.4 with some unmineralized regions while the ED group showed limited healing (2.6 \u00b1 0.2;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001 vs. all other groups). Micro-CT analysis demonstrated significant differences in TV and BV between the BH group treated with 210 \u03bcg of rhBMP-2 and that treated with 42 \u03bcg of rhBMP-2 (TV:\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.02; BV:\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.009), and between the ACS+2.1 mg rhBMP-2 group and the BH+42 \u03bcg rhBMP-2 group (BV:\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.05), with the higher dose BH group showing significantly lower values than the other rhBMP-2 groups. Notably, the BH+42 \u00b5g group showed superior bone structural quality, with the highest predicted torsional strength (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001 vs. all groups). Histological observations revealed that BH+210 \u00b5g rhBMP-2 generated the most mature and organized bone architecture, closely resembling native tissue. By contrast, BH+42 \u00b5g showed ongoing remodeling with residual cartilage, while in the ACS+2.1 mg group, the marrow space remained filled with dense bone. The ED group predominantly contained fibrocartilage and collapsed muscle within the defect.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCUSSION:<\/jats:title>\n                    <jats:p>This study demonstrated that the BH scaffold, an autologous biodegradable matrix, enabled delivery of ultra-low rhBMP-2 doses that achieved rapid and consistent bone regeneration and outperformed the clinically used ACS. This has significant clinical implications, as the BH scaffold offers a promising biomaterial-free solution for precise rhBMP-2 delivery, enhancing rapid bone regeneration while minimizing dosage, reducing adverse effects, and lowering treatment costs, making it an effective intervention for complex bone injuries.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bot.0000000000003165","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:06:38Z","timestamp":1774875998000},"page":"e156-e163","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Biomimetic Hematoma Promotes Superior Bone Regeneration With Ultra-low-Dose rhBMP-2 in a Goat Large-Defect Model"],"prefix":"10.1097","volume":"40","author":[{"given":"Vaida","family":"Glatt","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery, University of Texas Health Science Center, San Antonio, TX;"},{"name":"Sam and Ann Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center, San Antonio, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Aguilar","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, University of Texas Health Science Center, San Antonio, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Animesh","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, University of Texas Health Science Center, San Antonio, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Woloszyk","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, University of Texas Health Science Center, San Antonio, TX;"},{"name":"Sam and Ann Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center, San Antonio, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260612","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00264-015-2728-4","article-title":"Biological aspects of segmental bone defects management","volume":"39","author":"Dumic-Cule","year":"2015","journal-title":"Int Orthop."},{"issue":"suppl 2","key":"R2-20260612","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.injury.2021.01.043","article-title":"Autologous bone graft: is it still the gold standard?","volume":"52","author":"Schmidt","year":"2021","journal-title":"Injury"},{"key":"R3-20260612","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2106\/JBJS.E.00381","article-title":"Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial","volume":"88","author":"Jones","year":"2006","journal-title":"J Bone Joint Surg Am."},{"key":"R4-20260612","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/BOT.0000000000001492","article-title":"A randomized controlled trial comparing rhBMP-2\/Absorbable collagen sponge versus autograft for the treatment of Tibia fractures with critical size defects","volume":"33","year":"2019","journal-title":"J Orthop Trauma."},{"key":"R5-20260612","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/ten.teb.2015.0357","article-title":"A review of the clinical side effects of bone morphogenetic Protein-2","volume":"22","author":"James","year":"2016","journal-title":"Tissue Eng Part B Rev."},{"key":"R6-20260612","doi-asserted-by":"crossref","first-page":"110805","DOI":"10.1016\/j.compositesb.2023.110805","article-title":"Advances in the application of bone morphogenetic proteins and their derived peptides in bone defect repair","volume":"262","author":"Liu","year":"2023","journal-title":"Compos Part B Eng."},{"key":"R7-20260612","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/ijms23010283","article-title":"Enhanced BMP-2-mediated bone repair using an anisotropic silk fibroin scaffold coated with bone-like apatite","volume":"23","author":"Deininger","year":"2021","journal-title":"Int J Mol Sci."},{"key":"R8-20260612","doi-asserted-by":"crossref","first-page":"119278","DOI":"10.1016\/j.biomaterials.2019.119278","article-title":"Expanded skeletal stem and progenitor cells promote and participate in induced bone regeneration at subcritical BMP-2 dose","volume":"217","author":"Papageorgiou","year":"2019","journal-title":"Biomaterials"},{"key":"R9-20260612","doi-asserted-by":"crossref","first-page":"e2100088","DOI":"10.1002\/mabi.202100088","article-title":"Regenerating critical size rat segmental bone defects with a self-healing hybrid nanocomposite hydrogel: effect of bone condition and BMP-2 incorporation","volume":"21","author":"van Houdt","year":"2021","journal-title":"Macromol Biosci."},{"key":"R10-20260612","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jor.24170","article-title":"Cellular biology of fracture healing","volume":"37","author":"Bahney","year":"2019","journal-title":"J Orthop Res."},{"key":"R11-20260612","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1002\/term.2190","article-title":"Structural properties of fracture haematoma: current status and future clinical implications","volume":"11","author":"Wang","year":"2017","journal-title":"J Tissue Eng Regen Med."},{"key":"R12-20260612","doi-asserted-by":"crossref","first-page":"213027","DOI":"10.1016\/j.bioadv.2022.213027","article-title":"Fracture hematoma micro-architecture influences transcriptional profile and plays a crucial role in determining bone healing outcomes","volume":"139","author":"Woloszyk","year":"2022","journal-title":"Biomater Adv."},{"key":"R13-20260612","doi-asserted-by":"crossref","first-page":"213366","DOI":"10.1016\/j.bioadv.2023.213366","article-title":"Biomimetic hematoma delivers an ultra-low dose of rhBMP-2 to successfully regenerate large femoral bone defects in rats","volume":"148","author":"Woloszyk","year":"2023","journal-title":"Biomater Adv."},{"key":"R14-20260612","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/BOT.0000000000002692","article-title":"Biomimetic hematoma as a novel delivery vehicle for rhBMP-2 to potentiate the healing of nonunions and bone defects","volume":"37","author":"Glatt","year":"2023","journal-title":"J Orthop Trauma."},{"key":"R15-20260612","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.CC.25.00267","article-title":"Biomimetic hematoma enables healing in a recalcitrant nonunion with chronic osteomyelitis and 20 prior surgeries: a case report","volume":"15","author":"Maestas","year":"2025","journal-title":"JBJS Case Connect."},{"key":"R16-20260612","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2106\/JBJS.20.00380","article-title":"Reverse dynamization accelerates bone-healing in a large-animal osteotomy model","volume":"103","author":"Glatt","year":"2021","journal-title":"J Bone Joint Surg Am."},{"key":"R17-20260612","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/jor.22896","article-title":"Combination therapy with PTH and DBM cannot heal a critical sized murine femoral defect","volume":"33","author":"Pensak","year":"2015","journal-title":"J Orthop Res."},{"key":"R18-20260612","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2106\/00004623-199274050-00005","article-title":"The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats","volume":"74","author":"Yasko","year":"1992","journal-title":"J Bone Joint Surg Am."},{"key":"R19-20260612","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2106\/JBJS.22.01342","article-title":"Reverse dynamization accelerates regenerate bone formation and remodeling in a goat distraction osteogenesis model","volume":"105","author":"Bafor","year":"2023","journal-title":"J Bone Joint Surg Am."},{"key":"R20-20260612","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bone.2005.06.010","article-title":"Silk implants for the healing of critical size bone defects","volume":"37","author":"Meinel","year":"2005","journal-title":"Bone"},{"key":"R21-20260612","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bone.2005.07.028","article-title":"The use of micro-CT to evaluate cortical bone geometry and strength in nude rats: correlation with mechanical testing, pQCT and DXA","volume":"38","author":"Bagi","year":"2006","journal-title":"Bone"},{"key":"R22-20260612","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jbiomech.2010.09.022","article-title":"Non-invasive assessment of failure torque in rat bones with simulated lytic lesions using computed tomography based structural rigidity analysis","volume":"44","author":"Entezari","year":"2011","journal-title":"J Biomech."},{"key":"R23-20260612","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1097\/OI9.0000000000000249","article-title":"Great debates in trauma biomechanics","volume":"6","author":"Glatt","year":"2023","journal-title":"OTA Int."},{"key":"R24-20260612","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1097\/OI9.0000000000000304","article-title":"Biomechanics of fracture healing: how best to optimize your construct in the OR","volume":"7","author":"Hast","year":"2024","journal-title":"OTA Int."},{"key":"R25-20260612","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.spinee.2011.04.023","article-title":"A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned","volume":"11","author":"Carragee","year":"2011","journal-title":"Spine J."},{"key":"R26-20260612","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1007\/s11095-017-2147-x","article-title":"Formulation, delivery and stability of bone morphogenetic proteins for effective bone regeneration","volume":"34","author":"El Bialy","year":"2017","journal-title":"Pharm Res."},{"key":"R27-20260612","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/jor.23577","article-title":"Low-dose BMP-2 and MSC dual delivery onto coral scaffold for critical-size bone defect regeneration in sheep","volume":"35","author":"Decambron","year":"2017","journal-title":"J Orthop Res."},{"key":"R28-20260612","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/milmed\/usab360","article-title":"Bone morphogenetic Protein-2 rapidly heals two distinct critical sized segmental diaphyseal bone defects in a porcine model","volume":"188","author":"McKinley","year":"2023","journal-title":"Mil Med."}],"container-title":["Journal of Orthopaedic Trauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000003165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:00:23Z","timestamp":1781269223000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000003165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/bot.0000000000003165","relation":{},"ISSN":["0890-5339","1531-2291"],"issn-type":[{"value":"0890-5339","type":"print"},{"value":"1531-2291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2026-02-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}